E Botteri

Summary

Affiliation: European Institute of Oncology
Country: Italy

Publications

  1. ncbi Role of breast surgery in T1-3 breast cancer patients with synchronous bone metastases
    Edoardo Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 138:303-10. 2013
  2. ncbi Biopsy of liver metastasis for women with breast cancer: impact on survival
    Edoardo Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Breast 21:284-8. 2012
  3. ncbi Analysis of local and regional recurrences in breast cancer after conservative surgery
    E Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
    Ann Oncol 21:723-8. 2010
  4. ncbi Axillary lymph node involvement in women with breast cancer: does it depend on age?
    Edoardo Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Clin Breast Cancer 10:318-21. 2010
  5. ncbi Cigarette smoking and adenomatous polyps: a meta-analysis
    Edoardo Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Gastroenterology 134:388-95. 2008
  6. ncbi Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcome
    E Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Ann Oncol 20:1008-12. 2009
  7. ncbi Smoking and colorectal cancer: a meta-analysis
    Edoardo Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milano, Italy
    JAMA 300:2765-78. 2008
  8. ncbi The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series
    U Veronesi
    European Institute of Oncology, Milan, Italy
    Ann Oncol 19:1553-60. 2008
  9. ncbi Oncological results of immediate breast reconstruction: long term follow-up of a large series at a single institution
    J Y Petit
    Department of Plastic Surgery, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 112:545-9. 2008
  10. ncbi Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction
    M C Kneubil
    Division of Plastic Reconstruction Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy
    Eur J Surg Oncol 39:260-5. 2013

Collaborators

Detail Information

Publications36

  1. ncbi Role of breast surgery in T1-3 breast cancer patients with synchronous bone metastases
    Edoardo Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 138:303-10. 2013
    ..In this large and homogeneous series of MBC patients with synchronous bone metastases, the role of breast surgery had a favorable impact on both disease progression and mortality...
  2. ncbi Biopsy of liver metastasis for women with breast cancer: impact on survival
    Edoardo Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Breast 21:284-8. 2012
    ..Biopsy of metastatic site of disease can influence treatment decisions, but its impact on survival remains uncertain...
  3. ncbi Analysis of local and regional recurrences in breast cancer after conservative surgery
    E Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
    Ann Oncol 21:723-8. 2010
    ..A minority of patients treated conservatively for breast cancer will develop local or regional recurrences. Our aim was to determine how their occurrence may be linked to the evolution of the disease...
  4. ncbi Axillary lymph node involvement in women with breast cancer: does it depend on age?
    Edoardo Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Clin Breast Cancer 10:318-21. 2010
    ..We studied the specific relationship between lymph node (LN) involvement and age...
  5. ncbi Cigarette smoking and adenomatous polyps: a meta-analysis
    Edoardo Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Gastroenterology 134:388-95. 2008
    ..We performed a meta-analysis to provide a quantitative pooled risk estimate of the association, focusing on the different characteristics of the study populations, study designs, and clinical feature of the polyps...
  6. ncbi Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcome
    E Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Ann Oncol 20:1008-12. 2009
    ..In the case of ipsilateral breast tumour recurrence (IBTR) after breast-conserving surgery (BCS), a second conservative surgical approach maybe considered in some motivated patients whereas in others mastectomy is unavoidable...
  7. ncbi Smoking and colorectal cancer: a meta-analysis
    Edoardo Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milano, Italy
    JAMA 300:2765-78. 2008
    ..Colorectal cancer is the third most common form of cancer and the fourth most frequent cause of cancer deaths worldwide. The association between cigarette smoking and colorectal cancer has been inconsistent among studies...
  8. ncbi The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series
    U Veronesi
    European Institute of Oncology, Milan, Italy
    Ann Oncol 19:1553-60. 2008
    ..We assume that this excellent result is due to radiotherapy to internal mammary nodes and we propose that exploration of internal mammary nodes should be part of the staging process of carcinomas of the medial part of the breast...
  9. ncbi Oncological results of immediate breast reconstruction: long term follow-up of a large series at a single institution
    J Y Petit
    Department of Plastic Surgery, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 112:545-9. 2008
    ..However, a delay in the reconstruction is usually proposed after the mastectomy in case of invasive cancer, while there is a general agreement for immediate breast reconstruction in case of in situ tumors...
  10. ncbi Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction
    M C Kneubil
    Division of Plastic Reconstruction Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy
    Eur J Surg Oncol 39:260-5. 2013
    ..The LRR also varies according to breast cancer subtypes and clinicopathological features...
  11. ncbi Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution
    E Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 134:1221-8. 2012
    ..PVI and Ki-67 might help tailoring PMRT indications among patients with positive LNs. Finally, the very low incidence of recurrences in the axillary LNs raises questions about the inclusion of the axilla in the radiation field...
  12. ncbi Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institution
    O Gentilini
    Division of Breast Surgery, European Institue of Oncology, Milan, Italy
    Ann Oncol 18:1342-7. 2007
    ..The aim of this study was to describe outcomes of patients who underwent mastectomy without radiotherapy in a single institution...
  13. ncbi Risk factors associated with recurrence after nipple-sparing mastectomy for invasive and intraepithelial neoplasia
    J Y Petit
    Division of Plastic Surgery, European Institute of Oncology, Milan, Italy
    Ann Oncol 23:2053-8. 2012
    ..To identify risk factors of recurrence in a large series of patients with breast cancer who underwent a nipple-sparing mastectomy (NSM)...
  14. ncbi Prognostic role of CA15.3 in 7942 patients with operable breast cancer
    M T Sandri
    Division of Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Breast Cancer Res Treat 132:317-26. 2012
    ..3 value is an independent prognostic factor for metastases and deaths. CA15.3 provides additional information to the common prognostic factors and should be considered in the adjuvant therapeutic algorithm...
  15. ncbi When can a second conservative approach be considered for ipsilateral breast tumour recurrence?
    O Gentilini
    Division of Breast Surgery, European Institute of Oncology, Milan, Italy
    Ann Oncol 18:468-72. 2007
    ..Mastectomy is considered the treatment of choice in patients with ipsilateral breast tumour recurrence (IBTR) after breast-conserving surgery (BCS)...
  16. ncbi Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype
    M Lazzeroni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Br J Cancer 108:1593-601. 2013
    ....
  17. ncbi Outcome and clinical-biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases
    E Munzone
    Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milano, Italy
    Ann Oncol 23:2884-90. 2012
    ..Patients with metastatic breast cancer to the ovary, without tumor debulking and after systemic therapy, have a 5-year survival rate < 10%...
  18. ncbi Locoregional recurrence risk after lipofilling in breast cancer patients
    J Y Petit
    Division of Plastic Surgery, European Institute of Oncology, Milan, Italy
    Ann Oncol 23:582-8. 2012
    ..The clinical literatures underline its technical efficacy but experimental studies raise important questions about the potential detrimental effect of adipocytes on the stimulation of cancer growth and reappearance...
  19. ncbi Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study
    A Guerrieri-Gonzaga
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Ann Oncol 21:949-54. 2010
    ..Since low-dose tamoxifen showed a favorable modulation of breast cancer biomarkers in phase II trials, a monoinstitutional cohort of women with DIN treated with low-dose tamoxifen or no systemic treatment was analyzed...
  20. ncbi Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications
    F Nole
    Division of Medical Oncology, Medical Care Unit, European Institute of Oncology, Milano, Italy
    Ann Oncol 19:891-7. 2008
    ..This study aimed to evaluate the prognostic significance of circulating tumor cells (CTCs) detection in advanced breast cancer patients...
  21. ncbi Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection
    R Biffi
    Division of Abdomino Pelvic Surgery, European Institute of Oncology, Via Ripamonti 435, I 20141 Milan, Italy
    Eur J Surg Oncol 37:305-11. 2011
    ..This study was designed to establish whether the number of lymph nodes removed has an effect on prognosis in patients with node-negative gastric cancer...
  22. ncbi Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer
    Elisabetta Munzone
    Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Breast Cancer Res Treat 134:277-82. 2012
    ..3 (95% CI 1.0-5.8, P=0.046). Within the group of patients with node-negative TNBC, Ki-67LI was associated with different prognoses subgroups. Ki-67LI might be useful in the design of trials of risk-adapted adjuvant therapies...
  23. ncbi Nipple-sparing mastectomy: risk of nipple-areolar recurrences in a series of 579 cases
    J Y Petit
    Department of Plastic Surgery, European Institute of Oncology, Via Ripamonti 435, Milan, 20 141, Italy
    Breast Cancer Res Treat 114:97-101. 2009
    ..The risk of local recurrence behind the nipple areolar complex (NAC) is the main limiting factor of the NSM procedure. To minimize such risk, we proposed in 2002 a intraoperative radiotherapy of the preserved NAC...
  24. ncbi Brain metastases in patients with advanced breast cancer
    G Sanna
    Department of Oncology, European Institute of Oncology, Milan, Italy
    Anticancer Res 27:2865-9. 2007
    ..The incidence of brain metastases (BM) is apparently rising in patients with advanced breast cancer (ABC). We performed a case control study to define current features of breast cancer related to central nervous system (CNS) metastases...
  25. ncbi Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study)
    F Landoni
    Department of Gynecology Oncology, European Institute of Oncology EIO, Milan, Italy
    Int J Gynecol Cancer 17:623-8. 2007
    ....
  26. ncbi High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors
    E Cocorocchio
    Haematoncology Division, European Institute of Oncology, Milan, Italy
    Hematol Oncol 31:34-40. 2013
    ..HDCT is able to induce a high remission rate and a prolonged PFS in more than 50% of the patients with refractory and relapsed HL...
  27. ncbi Light alcohol drinking and cancer: a meta-analysis
    V Bagnardi
    Department of Statistics, University of Milan Bicocca, Milan, Italy
    Ann Oncol 24:301-8. 2013
    ..Most of the data derive from studies that focused on the effect of moderate/high alcohol intakes, while little is known about light alcohol drinking (up to 1 drink/day)...
  28. ncbi Case mix at the European Institute of Oncology: first report of the Tumour Registry, 2000-2002
    E Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
    Ecancermedicalscience 3:149. 2009
    ..The purpose of this paper is to describe the development of the TR at the European Institute of Oncology (IEO), Milan, Italy, from its origin to its current applications...
  29. ncbi Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature
    Alberto Luini
    Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Breast Cancer Res Treat 105:81-5. 2007
    ..We report the experience of the European Institute of Oncology with this unusual disease from January 1996 to January 2006: sixteen patients with angiosarcoma, 9 (56%) of whom had primary AB and 7 (44%), secondary AB, are discussed...
  30. ncbi Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps
    Patrick Maisonneuve
    Gastroenterology 135:710; author reply 710-1. 2008
  31. ncbi Tobacco smoking and cancer: a meta-analysis
    Sara Gandini
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Int J Cancer 122:155-64. 2008
    ..The analysis of heterogeneity showed that study type, gender and adjustment for confounding factors significantly influence the RRs estimates and the reliability of the studies...
  32. ncbi Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of Oncology
    Viviana Galimberti
    Department of Senology, European Institute of Oncology, Milan, Italy
    Tumori 94:52-8. 2008
    ..We performed a retrospective analysis of patients with 4 or more axillary nodes involved and sufficient follow-up to provide indications as to whether our current treatment is adequate...
  33. ncbi Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive prostate cancer
    Concetta De Cicco
    Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy
    Curr Cancer Drug Targets 8:199-206. 2008
    ..Better specific care could be provided to the aggressive phenotype-group of patients if pre-surgical identification were available...
  34. ncbi Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature
    Alberto Luini
    Division of Breast Surgery, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 101:349-53. 2007
    ..The purpose of the present study was to compare the clinical course, and prognosis, between this type of tumor and poorly differentiated ductal carcinoma...
  35. ncbi Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis
    Debora Macis
    Division of Chemoprevention, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 106:263-71. 2007
    ..A reduced activity of methylenetetrahydrofolate reductase (MTHFR) due to frequent C677T polymorphism affects DNA synthesis, repair and methylation and may be implicated in breast cancer risk...
  36. ncbi Empirical-Bayes adjustment improved conventional estimates in postmarketing drug-safety studies
    Vincenzo Bagnardi
    Department of Statistics, University of Milan-Bicocca, Milan, Italy
    J Clin Epidemiol 59:1162-8. 2006
    ..Macrolides and Quinolones were associated with the highest number of positive signals of dysrhythmic events. This requires further investigation by other types of epidemiologic studies...